127 related articles for article (PubMed ID: 14659820)
1. Binding of cocaine-like radioligands to the dopamine transporter at 37 degrees C: effect of Na+ and substrates.
Wang LC; Cui XN; Chen N; Reith ME
J Neurosci Methods; 2003 Dec; 131(1-2):27-33. PubMed ID: 14659820
[TBL] [Abstract][Full Text] [Related]
2. Na+ stimulates binding of dopamine to the dopamine transporter in cells but not in cell-free preparations.
Chen N; Rickey J; Reith ME
J Neurochem; 2003 Aug; 86(3):678-86. PubMed ID: 12859681
[TBL] [Abstract][Full Text] [Related]
3. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
Li LB; Cui XN; Reith MA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655
[TBL] [Abstract][Full Text] [Related]
4. Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl)tropane.
Chen N; Sun L; Reith ME
J Neurochem; 2002 Jun; 81(6):1383-93. PubMed ID: 12068085
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Na+, K+, and Cl- with the binding of amphetamine, octopamine, and tyramine to the human dopamine transporter.
Li LB; Reith ME
J Neurochem; 2000 Apr; 74(4):1538-52. PubMed ID: 10737611
[TBL] [Abstract][Full Text] [Related]
6. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
7. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.
Chen N; Reith ME
J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531
[TBL] [Abstract][Full Text] [Related]
8. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
Wall SC; Innis RB; Rudnick G
Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.
Lin Z; Wang W; Kopajtic T; Revay RS; Uhl GR
Mol Pharmacol; 1999 Aug; 56(2):434-47. PubMed ID: 10419565
[TBL] [Abstract][Full Text] [Related]
10. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells.
Page G; Chalon S; Emond P; Maloteaux JM; Hermans E
Neurochem Int; 2002 Feb; 40(2):105-13. PubMed ID: 11738476
[TBL] [Abstract][Full Text] [Related]
12. Novel tropane-based irreversible ligands for the dopamine transporter.
Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
[TBL] [Abstract][Full Text] [Related]
13. Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter.
Li LB; Reith ME
J Neurochem; 1999 Mar; 72(3):1095-109. PubMed ID: 10037481
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter.
Dutta AK; Reith ME; Madras BK
Synapse; 2001 Feb; 39(2):175-81. PubMed ID: 11180505
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
Lin Z; Wang W; Uhl GR
Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
[TBL] [Abstract][Full Text] [Related]
16. [3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue.
Kula NS; Baldessarini RJ; Tarazi FI; Fisser R; Wang S; Trometer J; Neumeyer JL
Eur J Pharmacol; 1999 Dec; 385(2-3):291-4. PubMed ID: 10607889
[TBL] [Abstract][Full Text] [Related]
17. Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists.
Slusher BS; Tiffany CW; Olkowski JL; Jackson PF
Drug Alcohol Depend; 1997 Oct; 48(1):43-50. PubMed ID: 9330920
[TBL] [Abstract][Full Text] [Related]
18. N-substituted analogs of 2 beta-carbomethoxy-3 beta- (4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain.
Neumeyer JL; Tamagnan G; Wang S; Gao Y; Milius RA; Kula NS; Baldessarini RJ
J Med Chem; 1996 Jan; 39(2):543-8. PubMed ID: 8558525
[TBL] [Abstract][Full Text] [Related]
19. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T
Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
[TBL] [Abstract][Full Text] [Related]
20. Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N
Synapse; 2001 Dec; 42(4):273-80. PubMed ID: 11746726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]